Holen Sie sich die Stockscreener-App
82.50
3.66%
2.91
Handel nachbörslich:
82.79
0.29
+0.35%
Grail Inc Aktie (GRAL) Neueste Nachrichten
Why Is GRAL Stock Down Today? Analysts Lower Targets After UK Trial Setback But Call Selloff Overdone - Stocktwits
Biotech Frenzy Sends GRAIL Soaring Ahead of FDA Showdown - TipRanks
Investigation announced for Long-Term Investors in shares of GRAIL, Inc. (NASDAQ: GRAL) over potential Wrongdoing - openPR.com
GRAIL (GRAL) Earnings Report: Profit Per Share Surpasses Its Benchmark in the Current Update; Post-Report: The Market Price Advances 6.19% in Latest TradingGross Profit Margin - dars.gov.et
Grail Stock Rockets Back As Traders Buy The Dip - TipRanks
GRAIL (GRAL), What Is Behind The Fresh Attention On The Stock? - simplywall.st
Why Silver Grail Resources Ltd stock is skyrocketing today - Wealth Awesome
Russell Investments Group Ltd. Has $1.94 Million Holdings in GRAIL, Inc. $GRAL - MarketBeat
GRAL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
How (GRAL) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
GRAL Q2 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineEarnings Season Review - Vinanet
GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting - MarketBeat
GRAL|Grail Inc|Price:68.180|Chg%:-0.760 - TradingKey
Farallon group discloses 9.6% GRAIL, Inc. (GRAL) holding in Schedule 13G/A - Stock Titan
GRAIL Q2 2026 Earnings: EPS Beats Estimates by 5.37% Amid Muted Stock ReactionEarnings Acceleration Picks - Vinanet
GRAIL Inc. (GRAL) Edges Lower 0.84% as Shares Hold Above $64.94 SupportValue Area Low - Vinanet
GRAIL, Inc. (NASDAQ:GRAL) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Bank of America Corp DE Purchases 205,611 Shares of GRAIL, Inc. $GRAL - MarketBeat
GRAIL: Looking Beyond The NHS-Galleri Headline (NASDAQ:GRAL) - Seeking Alpha
GRAIL (NASDAQ:GRAL) Stock Price Down 6.3%What's Next? - MarketBeat
Cancer Detection Firm Nears FDA Breakthrough Blood-Test Review - Streetwise Reports
GRAIL Galleri Test Heads to FDA Panel for Multi-Cancer Screening Review - Streetwise Reports
GRAIL INC : PIPER SANDLER RAISES TARGET PRICE TO $74 FROM $56 - webull.com
FDA panel to review GRAIL’s Galleri multi-cancer blood test in September - Mugglehead Investment Magazine
GRAIL (NASDAQ:GRAL) Trading Up 7.6%Time to Buy? - marketbeat.com
FDA Panel Schedules to Evaluate GRAIL Premarket Approval Application for Multi-Cancer Early Detection Test - Benzinga
FDA panel to weigh Grail’s Galleri test - STAT
GRAIL’s Galleri becomes first multi-cancer detection test headed to US FDA advisory panel - AllSci
Renaissance Technologies LLC Sells 30,100 Shares of GRAIL, Inc. $GRAL - MarketBeat
Illumina Seeks Court Approval of GRAIL Settlement - The Globe and Mail
GRAIL Inc Revenue Breakdown – LSX:A40F8M - TradingView
Is GRAIL (GRAL) Fairly Valued Following Galleri Adoption Growth And The FDA Panel Date? - Yahoo Finance
US FDA to hold advisory meeting to review Grail’s multi-cancer test - WTVB
US FDA to hold advisory meeting to review Grail's multi-cancer test - Reuters
FDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints News
FDA panel to review GRAIL’s cancer detection test on Sept. 23 - Investing.com
GRAIL Insiders Sold US$29m Of Shares Suggesting Hesitancy - Moomoo
GRAIL to face FDA AdCom for Galleri cancer test (GRAL:NASDAQ) - Seeking Alpha
GRAIL Says FDA Advisory Committee To Review GRAIL Galleri PMA Application On September 23 - TradingView
GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test - PR Newswire
Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and SanDisk Corp (SNDK) - The Globe and Mail
State Street Corporation (NASDAQ: GRAL) reports 5.6% beneficial stake in GRAIL - Stock Titan
GRAIL Bets Its Galleri Panel Will Set The FDA Bar For Future MCEDs - insights.citeline.com
Dimensional Fund Advisors LP Purchases 191,857 Shares of GRAIL, Inc. $GRAL - marketbeat.com
PRIMECAP Management (GRAL) discloses 21.8M-share, 5.08% stake in GRAIL - Stock Titan
GRAIL, Inc. 2026: Revenue $44.69M, EPS ($2.56) — 10-Q Summary - TradingView
[10-Q] GRAIL, Inc. Quarterly Earnings Report - Stock Titan
GRAIL (NASDAQ:GRAL) Shares Down 12.2%What's Next? - MarketBeat
GRAL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
GRAIL, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
GRAIL Inc (GRAL) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
GRAIL INC Q2 NET INCOME USD -110.247 MILLION - Moomoo
GRAIL Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: GRAIL beats revenue in Q2 2026, shares fall after hours - Investing.com
GRAIL (NASDAQ:GRAL) Announces Earnings Results - MarketBeat
GRAIL shares tumble despite revenue beat on Q2 results By Investing.com - Investing.com Nigeria
Grail Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings Flash (GRAL) GRAIL, Inc. Reports Q2 Revenue $44.7M, vs. FactSet Est of $42.4M - marketscreener.com
Grail reports Q2 2026 revenue up 26% to $44.7M; net loss $110.2M - TradingView
GRAIL (Nasdaq: GRAL) Q2 revenue rises 26% as net loss narrows - stocktitan.net
GRAIL Reports Second Quarter 2026 Financial Results - TradingView
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026 - Morningstar
0.24%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):